COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Distinguishing cardiac syncope from vasovagal syncope in a referral population.

Journal of Pediatrics 2013 December
OBJECTIVE: To identify characteristics that distinguish cardiac from vasovagal syncope.

STUDY DESIGN: We compared characteristics of patients ≤18 years of age with vasovagal and cardiac syncope. Vasovagal syncope subjects represented all patients presenting to outpatient cardiology during a 1-year period for initial evaluation of syncope diagnosed with vasovagal syncope. Cardiac patients were all patients identified by review of diagnoses known to include syncope as a symptom who presented with syncope to the emergency department or inpatient or outpatient cardiology during a 10-year period identified with cardiac etiology.

RESULTS: There were 89 patients 4-18 years of age with vasovagal syncope and 17 patients 4 months to 17 years of age with cardiac syncope. When we compared patients with cardiac syncope to those with vasovagal syncope, we found that syncope surrounding activity was present in 65% vs 18% (P < .001), family history of cardiac disease or sudden cardiac death was identified in 41% vs 25% (P = .2), abnormal findings on the physical examination supporting cardiac diagnosis were present in 29% vs 0% (P < .001), and abnormal findings on electrocardiograms were found in 76% vs 0%, respectively (P < .001). Screening for cardiac disease using any 1 of these 4 characteristics had a sensitivity of 100% and specificity of 60%. Using this screening rule, we found that 60% of patients with vasovagal syncope would not have been referred to cardiology.

CONCLUSIONS: Cardiac and vasovagal syncope have dramatic differences in presentation. A screening rule that uses historic features, physical examination findings, and electrocardiogram will accurately separate patients requiring further evaluation for cardiac etiology from those with vasovagal syncope in whom cardiology referral is unnecessary.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app